These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 31974811)

  • 21. Transarterial chemoembolization (TACE)-hepatic arterial infusion chemotherapy (HAIC) combined with PD-1 inhibitors plus lenvatinib as a preoperative conversion therapy for nonmetastatic advanced hepatocellular carcinoma: a single center experience.
    Zhao W; Liu C; Wu Y; Yao Z; Dou Q; Li W; Zhao X; Xia N
    Transl Cancer Res; 2024 May; 13(5):2315-2331. PubMed ID: 38881913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Choi JH; Chung WJ; Bae SH; Song DS; Song MJ; Kim YS; Yim HJ; Jung YK; Suh SJ; Park JY; Kim DY; Kim SU; Cho SB
    Cancer Chemother Pharmacol; 2018 Sep; 82(3):469-478. PubMed ID: 29982870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus.
    Nagai H; Mukozu T; Ogino YU; Matsui D; Matsui T; Wakui N; Momiyama K; Igarashi Y; Sumino Y; Higai K
    Anticancer Res; 2015 Apr; 35(4):2269-77. PubMed ID: 25862889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study.
    Yuan Y; He W; Yang Z; Qiu J; Huang Z; Shi Y; Lin Z; Zheng Y; Chen M; Lau WY; Li B; Yuan Y
    Int J Surg; 2023 May; 109(5):1222-1230. PubMed ID: 37026861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review.
    Tao ZW; Cheng BQ; Zhou T; Gao YJ
    Hepatobiliary Pancreat Dis Int; 2022 Apr; 21(2):134-144. PubMed ID: 34955380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY
    Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study.
    Ou X; Wu J; Wu J; Fu Y; Zeng Z; Li S; Li Y; Liu D; Li H; Li B; Zhou J; Zhuang S; Cheng S; Zhang Z; Wang K; Qu S; Yan M
    Cancer Res Treat; 2024 Oct; 56(4):1207-1218. PubMed ID: 38697847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.
    Kodama K; Kawaoka T; Aikata H; Uchikawa S; Nishida Y; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Kimura T; Nagata Y; Chayama K
    Oncology; 2018; 94(4):215-222. PubMed ID: 29428943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multidisciplinary treatment for advanced hepatocellular carcinoma with portal vein tumor thrombosis and adrenal/lung metastases].
    Mizumoto T; Beppu T; Okabe K; Sugiyama S; Nakagawa M; Okabe H; Doi K; Ishiko T; Yamanaka T; Egami H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1921-3. PubMed ID: 15553760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.
    Zheng K; Zhu X; Fu S; Cao G; Li WQ; Xu L; Chen H; Wu D; Yang R; Wang K; Liu W; Wang H; Bao Q; Liu M; Hao C; Shen L; Xing B; Wang X
    Radiology; 2022 May; 303(2):455-464. PubMed ID: 35103539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic Arterial Infusion Chemotherapy Followed by Lipiodol Infusion for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Single-Center Experience.
    Chen KT; Tsai KF; Leung HWC; Chan ALF; Wang SY; Liang HL; Tang SY; Chou CK; Chen HY; Chan SH; Li MF
    Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440985
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatocellular Carcinoma with Vp3 Tumor Thrombosis Treated with Multidisciplinary Treatment--Report of Two Cases].
    Mun Y; Yoshidome H; Shinmura K; Nishida T; Sato Y; Nakamura J; Kato K; Oki A; Sasaki S; Miyazaki M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1851-3. PubMed ID: 26805194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab for Advanced HCC: Two Case Reports.
    Tian Y; Jin W; Sun H; Jin D; Kang D; Li Z; Piao L
    J Hepatocell Carcinoma; 2023; 10():1587-1593. PubMed ID: 37791067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.
    Tan X; Xie P; Liu J; Wu H; Xie Y
    Asia Pac J Clin Oncol; 2015 Sep; 11(3):e6-e12. PubMed ID: 25228074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
    Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility and efficacy of single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolization.
    Shirai S; Sato M; Suwa K; Kishi K; Shimono C; Sonomura T; Kawai N; Tanihata H; Minamiguchi H; Nakai M
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1037-44. PubMed ID: 19540053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic arterial infusion oxaliplatin plus raltitrexed and chemoembolization in hepatocellular carcinoma with portal vein invasion: A propensity score-matching cohort study.
    Chen S; Yuan B; Yu W; Wang X; He C; Chen C
    J Surg Oncol; 2022 Dec; 126(7):1205-1214. PubMed ID: 35856502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of trans-hepatic arterial chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus.
    Akiyama M; Miyaaki H; Miuma S; Shibata H; Fujimoto M; Takeshita S; Ozawa E; Ichikawa T; Nakao K; Eguchi K
    Oncol Rep; 2008 Aug; 20(2):353-7. PubMed ID: 18636197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.
    Ahn YE; Suh SJ; Yim HJ; Seo YS; Yoon EL; Kim TH; Lee YS; Yim SY; Kim HR; Kang SH; Jung YK; Kim JH; Yeon JE; Um SH; Byun KS
    Gut Liver; 2021 Mar; 15(2):284-294. PubMed ID: 32307975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.